Proliferation models in tumours

International Journal of Radiation Biology

Volumn 79, Issue 7, 2003, Pages 525-530

  Wilson, G D ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P16; PROTEIN P21; PROTEIN P27; TRANSFORMING GROWTH FACTOR ALPHA;

CANCER RADIOTHERAPY; CARCINOGENESIS; CELL AGING; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; DNA SYNTHESIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENOTYPE; HUMAN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR CELL; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; CELL CYCLE; CELL DIVISION; DNA; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; TREATMENT FAILURE;

EID: 0142178062     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/0955300031000114710     Document Type: Conference Paper

References (20)

1. BAISCH, H. and OTTO, U., 1993, Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry. Cell Proliferation, 26, 439-448.
2. BAISCH, H., OTTO, U., HATJE, U. and FACK, H., 1995, Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling. Cytometry, 21, 52-61.
3. BARTKOVA, J., LUKAS, J. and BARTEK, J., 1997, Aberrations of the G1- and G1/S-regulating genes in human cancer. Progress in Cell Cycle Research, 3, 211-220.
4. BEGG, A. C., HAUSTERMANS, K., HART, A. A., DISCHE, S., SAUNDERS, M., ZACKRISSON, B., GUSTAFFSON, H., COUCKE, P., PASCHOUD, N., HOYER, M., OVERGAARD, J., ANTOGNONI, P., RICHETTI, A., BOURHIS, J., BARTELINK, H., HORIOT, J. C., CORVO, R., GIARETTI, W., AWWAD, H., SHOUMAN, T., JOUFFROY, T., MACIOROWSKI, Z., DOBROWSKY, W., STRUIKMANS, H. and WILSON, G. D., et al., 1999, The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiotherapy and Oncology, 50, 13-23.
5. DERYNCK, R., GOEDDEL, D. V., ULLRICH, A., GUTTERMAN, J. U., WILLIAMS, R. D., BRINGMAN, T. S. and BERGER, W. H., 1987, Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Research, 47, 707-712.
6. DISCHE, S., SAUNDERS, M., BARRETT, A., HARVEY, A., GIBSON, D. and PARMAR, M., 1997, A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology, 44, 123-136.
7. FIELD, J. K., 1992, Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. European Journal of Cancer B Oral Oncology, 28B, 67-76.
8. FRIDOVICH, K. J. L., HANSEN, L. J., KEYOMARSI, K. and PARDEE, A. B., 1990, Progression through the cell cycle: an overview. American Reviews in Respiratory Disease, 142, 3-6.
9. HANSEN, O., OVERGAARD, J., HANSEN, H. S., OVERGAARD, M., HOYER, M., JORGENSEN, K. E., BASTHOLT, L. and BERTHELSEN, A., 1997, Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiotherapy and Oncology, 43, 47-51.
10. HOCKEL, M. and VAUPEL, P., 2001, Biological consequences of tumor hypoxia. Seminars in Oncology, 28, 36-41.
11. HORIOT, J. C., BONTEMPS, P., VAN DEN BOGAERT, W., LE FUR, R., VAN DEN WEIJNGAERT, D., BOLLA, M., BERNIER, J., LUSINCHI, A., STUSCHKE, M., LOPEZ-TORRECILLA, J., BEGG, A. C., PIERART, M. and COLLETTE, L., 1997, Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial [see comments]. Radiotherapy and Oncology, 44, 111-121.
12. JUAN, G., LI, X. and DARZYNKIEWICZ, Z., 1997, Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells. Cancer Research, 57, 803-807.
13. OVERGAARD, J., HJELM-HANSEN, M., VENDELBO-JOHANSEN, L. and ANDERSEN, A. P., 1988, Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncologica, 27, 147-152.
14. SHACKNEY, S. E., 1974, A cytokinetic model for heterogeneous mammalian cell populations. II. Tritiated thymidine studies: the per cent labeled mitosis (PLM) curve. Journal of Theoretical Biology, 44, 49-90.
15. SHACKNEY, S. E. and SHANKEY, T. V., 1999, Cell cycle models for molecular biology and molecular oncology: exploring new dimensions. Cytometry, 35, 97-116.
16. SPORN, M. B. and TODARO, G. J., 1980, Autocrine secretion and malignant transformation of cells. New England Journal of Medicine, 303, 878-880.
17. STANTON, P., RICHARDS, S., REEVES, J., NIKOLIC, M., EDINGTON, K., CLARK, L., ROBERTSON, G., SOUTER, D., MITCHELL, R. HENDLER, F. J., et al., 1994, Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. British Journal of Cancer, 70, 427-433.
18. STEEL, G. G., 1977, Growth Kinetics of Tumours (Oxford: Clarendon).
19. STELL, P. M., 1991, Time to recurrence of squamous cell carcinoma of the head and neck. Head and Neck, 13, 277-281.
20. WITHERS, H. R., TAYLOR, J. M. and MACIEJEWSKI, B., 1988, The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncologica, 27, 131-146.